Cavin-3 dictates the balance between ERK and Akt signaling

eLife

Volumn 2013, Issue 2, 2013, Pages

  Hernandez, Victor J ^a   Weng, Jian ^a   Ly, Peter ^a   Pompey, Shanica ^a   Dong, Hongyun ^a   Mishra, Lopa ^b   Schwarz, Margaret ^c   Anderson, Richard G W ^a   Michaely, Peter ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CAVIN 3 PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; F ACTIN; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTIC ACID; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN I; PROTEIN KINASE B; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; PRKCDBP PROTEIN, HUMAN; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CACHEXIA; CAVEOLA; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MALE; MICROARRAY ANALYSIS; MOUSE; NICK END LABELING; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY; CELL LINE; ENZYME ACTIVATION; METABOLISM; PHYSIOLOGY;

APOPTOSIS; CELL LINE; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84884686593     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.00905     Document Type: Article

References (99)

1. Agarwal S, Corbley MJ, Roberts TM. 1995. Reconstitution of signal transduction from the membrane to the nucleus in a baculovirus expression system: activation of Raf-1 leads to hypermodification of c-jun and c-fos via multiple pathways. Oncogene 11:427-38.
2. Anderson RG, Kamen BA, Rothberg KG, Lacey SW. 1992. Potocytosis: sequestration and transport of small molecules by caveolae. Science 255:410-1. doi: 10.1126/science.1310359.
3. Aplin AE, Juliano RL. 1999. Integrin and cytoskeletal regulation of growth factor signaling to the MAP kinase pathway. J Cell Sci 112:695-706.
4. Asterholm IW, Mundy DI, Weng J, Anderson RG, Scherer PE. 2012. Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1. Cell Metab 15:171-85. doi: 10.1016/j.cmet.2012.01.004.
5. Baron V, Adamson ED, Calogero A, Ragona G, Mercola D. 2006. The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther 13:115-24. doi: 10.1038/sj.cgt.7700896.
6. Barylko B, Wagner MC, Reizes O, Albanesi JP. 1992. Purification and characterization of a mammalian myosin I. Proc Natl Acad Sci USA 89:490-4. doi: 10.1073/pnas.89.2.490.
7. Bastiani M, Liu L, Hill MM, Jedrychowski MP, Nixon SJ, Lo HP, et al. 2009. MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes. J Cell Biol 185:1259-73. doi: 10.1083/jcb.200903053.
8. Bennett V, Healy J. 2008. Organizing the fluid membrane bilayer: diseases linked to spectrin and ankyrin. Trends Mol Med 14:28-36. doi: 10.1016/j.molmed.2007.11.005.
9. Bond LM, Brandstaetter H, Kendrick-Jones J, Buss F. 2013. Functional roles for myosin 1c in cellular signaling pathways. Cell Signal 25:229-35. doi: 10.1016/j.cellsig.2012.09.026.
10. Boscher C, Nabi IR. 2012. Caveolin-1: role in cell signaling. Adv Exp Med Biol 729:29-50. doi: 10.1007/978-1-4614-1222-9_3.
11. Boucrot E, Howes MT, Kirchhausen T, Parton RG. 2011. Redistribution of caveolae during mitosis. J Cell Sci 124:1965-72. doi: 10.1242/jcs.076570.
12. Bradley EW, Ruan MM, Oursler MJ. 2008. Novel pro-survival functions of the Kruppel-like transcription factor Egr2 in promotion of macrophage colony-stimulating factor-mediated osteoclast survival downstream of the MEK/ERK pathway. J Biol Chem 283:8055-64. doi: 10.1074/jbc.M709500200.
13. Cagnol S, Chambard JC. 2010. ERK and cell death: mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence. FEBS J 277:2-21. doi: 10.1111/j.1742-4658.2009.07366.x.
14. Cao H, Alston L, Ruschman J, Hegele RA. 2008. Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia. Lipids Health Dis 7:3. doi: 10.1186/1476-511X-7-3.
15. Caren H, Djos A, Nethander M, Sjoberg RM, Kogner P, Enstrom C, et al. 2011. Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma. BMC Cancer 11:66. doi: 10.1186/1471-2407-11-66.
16. Cohen AW, Razani B, Wang XB, Combs TP, Williams TM, Scherer PE, et al. 2003. Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am J Physiol Cell Physiol 285:C222-35. doi: 10.1152/ajpcell.00006.2003.
17. Cohen DM. 1996. Urea-inducible Egr-1 transcription in renal inner medullary collecting duct (mIMCD3) cells is mediated by extracellular signal-regulated kinase activation. Proc Natl Acad Sci USA 93:11242-7. doi: 10.1073/pnas.93.20.11242.
18. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. 2008. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7:11-20. doi: 10.1016/j.cmet.2007.10.002.
19. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, et al. 2001. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293:2449-52. doi: 10.1126/science.1062688.
20. Duronio V. 2008. The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochem J 415:333-44. doi: 10.1042/BJ20081056.
21. Duvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, et al. 2010. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 39:171-83. doi: 10.1016/j.molcel.2010.06.022.
22. Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, et al. 1998. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett 428:205-11. doi: 10.1016/S0014-5793(98)00470-0.
23. Engelman JA, Luo J, Cantley LC. 2006. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7:606-19. doi: 10.1038/nrg1879.
24. Engelman JA, Zhang XL, Galbiati F, Lisanti MP. 1998. Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1,-2, and-3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31). FEBS Lett 429:330-6. doi: 10.1016/S0014-5793(98)00619-X.
25. Fang PK, Solomon KR, Zhuang L, Qi M, McKee M, Freeman MR, et al. 2006. Caveolin-1alpha and-1beta perform nonredundant roles in early vertebrate development. Am J Pathol 169:2209-22. doi: 10.2353/ajpath.2006.060562.
26. Fernandez I, Ying Y, Albanesi J, Anderson RG. 2002. Mechanism of caveolin filament assembly. Proc Natl Acad Sci USA 99:11193-8. doi: 10.1073/pnas.172196599.
27. Ferretti C, Bruni L, Dangles-Marie V, Pecking AP, Bellet D. 2007. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum Reprod Update 13:121-41. doi: 10.1093/humupd/dml048.
28. Foster LJ, De Hoog CL, Mann M. 2003. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci USA 100:5813-8. doi: 10.1073/pnas.0631608100.
29. Foti M, Porcheron G, Fournier M, Maeder C, Carpentier JL. 2007. The neck of caveolae is a distinct plasma membrane subdomain that concentrates insulin receptors in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 104:1242-7. doi: 10.1073/pnas.0610523104.
30. Fox KM, Brooks JM, Gandra SR, Markus R, Chiou CF. 2009. Estimation of cachexia among cancer patients based on four definitions. J Oncol 2009:693458. doi: 10.1155/2009/693458.
31. Furuchi T, Anderson RG. 1998. Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J Biol Chem 273:21099-104. doi: 10.1074/jbc.273.33.21099.
32. Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, Cobb MH, et al. 1995. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J 14:951-62.
33. Grigoriu A, Ferreira JC, Choufani S, Baczyk D, Kingdom J, Weksberg R. 2011. Cell specific patterns of methylation in the human placenta. Epigenetics 6:368-79. doi: 10.4161/epi.6.3.14196.
34. Guha M, Altieri DC. 2009. Survivin as a global target of intrinsic tumor suppression networks. Cell Cycle 8:2708-10. doi: 10.4161/cc.8.17.9457.
35. Guillemot L, Levy A, Raymondjean M, Rothhut B. 2001. Angiotensin II-induced transcriptional activation of the cyclin D1 gene is mediated by Egr-1 in CHO-AT(1A) cells. J Biol Chem 276:39394-403. doi: 10.1074/jbc.M103862200.
36. Hallahan DE, Sukhatme VP, Sherman ML, Virudachalam S, Kufe D, Weichselbaum RR. 1991. Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR1 and JUN. Proc Natl Acad Sci USA 88:2156-60. doi: 10.1073/pnas.88.6.2156.
37. Hansen CG, Shvets E, Howard G, Riento K, Nichols BJ. 2013. Deletion of cavin genes reveals tissue-specific mechanisms for morphogenesis of endothelial caveolae. Nat Commun 4:1831. doi: 10.1038/ncomms2808.
38. Hayashi YK, Matsuda C, Ogawa M, Goto K, Tominaga K, Mitsuhashi S, et al. 2009. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J Clin Invest 119:2623-33. doi: 10.1172/JCI38660.
39. Hill MM, Bastiani M, Luetterforst R, Kirkham M, Kirkham A, Nixon SJ, et al. 2008. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 132:113-24. doi: 10.1016/j.cell.2007.11.042.
40. Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T. 2005. Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin. Clin Exp Immunol 142:285-91. doi: 10.1111/j.1365-2249.2005.02912.x.
41. Huang-Doran I, Sleigh A, Rochford JJ, O'Rahilly S, Savage DB. 2010. Lipodystrophy: metabolic insights from a rare disorder. J Endocrinol 207:245-55. doi: 10.1677/JOE-10-0272.
42. Isshiki M, Ando J, Korenaga R, Kogo H, Fujimoto T, Fujita T, et al. 1998. Endothelial Ca2+ waves preferentially originate at specific loci in caveolin-rich cell edges. Proc Natl Acad Sci USA 95:5009-14. doi: 10.1073/pnas.95.9.5009.
43. Joshi B, Bastiani M, Strugnell SS, Boscher C, Parton RG, Nabi IR. 2012. Phosphocaveolin-1 is a mechanotransducer that induces caveola biogenesis via Egr1 transcriptional regulation. J Cell Biol 199:425-35. doi: 10.1083/jcb.201207089.
44. Kennedy SG, Kandel ES, Cross TK, Hay N. 1999. Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol Cell Biol 19:5800-10.
45. Kim CA, Delepine M, Boutet E, El Mourabit H, Le Lay S, Meier M, et al. 2008. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J Clin Endocrinol Metab 93:1129-34. doi: 10.1210/jc.2007-1328.
46. Kiss AL. 2012. Caveolae and the regulation of endocytosis. Adv Exp Med Biol 729:14-28. doi: 10.1007/978-1-4614-1222-9_2.
47. Kumar S, Park SH, Cieply B, Schupp J, Killiam E, Zhang F, et al. 2011. A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition. Mol Cell Biol 31:4036-51. doi: 10.1128/MCB.01342-10.
48. Lee JH, Byun DS, Lee MG, Ryu BK, Kang MJ, Chae KS, et al. 2008. Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses. Int J Cancer 122:1573-84. doi: 10.1002/ijc.23166.
49. Lee JH, Kang MJ, Han HY, Lee MG, Jeong SI, Ryu BK, et al. 2011. Epigenetic alteration of PRKCDBP in colorectal cancers and its implication in tumor cell resistance to TNFalpha-induced apoptosis. Clin Cancer Res 17:7551-62. doi: 10.1158/1078-0432.CCR-11-1026.
50. Lin MT, Adelman JP, Maylie J. 2012. Modulation of endothelial SK3 channel activity by Ca(2)+dependent caveolar trafficking. Am J Physiol Cell Physiol 303:C318-27. doi: 10.1152/ajpcell.00058.2012.
51. Lin SK, Kok SH, Yeh FT, Kuo MY, Lin CC, Wang CC, et al. 2004. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor. Arthritis Rheum 50:785-93. doi: 10.1002/art.20058.
52. Liu L, Brown D, McKee M, Lebrasseur NK, Yang D, Albrecht KH, et al. 2008. Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance. Cell Metab 8:310-7. doi: 10.1016/j.cmet.2008.07.008.
53. Liu L, Pilch PF. 2008. A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization. J Biol Chem 283:4314-22. doi: 10.1074/jbc.M707890200.
54. Liu P, Ying Y, Anderson RG. 1997. Platelet-derived growth factor activates mitogen-activated protein kinase in isolated caveolae. Proc Natl Acad Sci USA 94:13666-70. doi: 10.1073/pnas.94.25.13666.
55. Liu P, Ying Y, Ko YG, Anderson RG. 1996. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J Biol Chem 271:10299-303. doi: 10.1074/jbc.271.17.10299.
56. Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Lodish HF. 1997. Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci USA 94:10669-74. doi: 10.1073/pnas.94.20.10669.
57. Lunt SY, Vander Heiden MG. 2011. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27:441-64. doi: 10.1146/annurev-cellbio-092910-154237.
58. Manning BD, Cantley LC. 2007. AKT/PKB signaling: navigating downstream. Cell 129:1261-74. doi: 10.1016/j.cell.2007.06.009.
59. Martin S, Fernandez-Rojo MA, Stanley AC, Bastiani M, Okano S, Nixon SJ, et al. 2012. Caveolin-1 deficiency leads to increased susceptibility to cell death and fibrosis in white adipose tissue: characterization of a lipodystrophic model. PLOS ONE 7:e46242. doi: 10.1371/journal.pone.0046242.
60. Martinez R, Martin-Subero JI, Rohde V, Kirsch M, Alaminos M, Fernandez AF, et al. 2009. A microarray-based DNA methylation study of glioblastoma multiforme. Epigenetics 4:255-64.
61. McMahon KA, Zajicek H, Li WP, Peyton MJ, Minna JD, Hernandez VJ, et al. 2009. SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function. EMBO J 28:1001-15. doi: 10.1038/emboj.2009.46.
62. Michaely P, Hernandez VJ, Weng J, Ly P, Pompey S, Dong H, et al. 2013. Data from: cavin-3 dictates the balance between ERK and Akt signaling. Dryad Digital Repository. doi: 10.5061/dryad.4950k.
63. Mineo C, James GL, Smart EJ, Anderson RG. 1996. Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J Biol Chem 271:11930-5. doi: 10.1074/jbc.271.20.11930.
64. Mineo C, Shaul PW. 2012. Regulation of eNOS in caveolae. Adv Exp Med Biol 729:51-62. doi: 10.1007/978-1-4614-1222-9_4.
65. Mishra L, Shetty K, Tang Y, Stuart A, Byers SW. 2005. The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer. Oncogene 24:5775-89. doi: 10.1038/sj.onc.1208924.
66. Nagy P, Claus J, Jovin TM, Arndt-Jovin DJ. 2010. Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis. Proc Natl Acad Sci USA 107:16524-9. doi: 10.1073/pnas.1002642107.
67. Nassoy P, Lamaze C. 2012. Stressing caveolae new role in cell mechanics. Trends Cell Biol 22:381-9. doi: 10.1016/j.tcb.2012.04.007.
68. Ochsner SA, Day AJ, Rugg MS, Breyer RM, Gomer RH, Richards JS. 2003. Disrupted function of tumor necrosis factor-alpha-stimulated gene 6 blocks cumulus cell-oocyte complex expansion. Endocrinology 144:4376-84. doi: 10.1210/en.2003-0487.
69. Ogata T, Ueyama T, Isodono K, Tagawa M, Takehara N, Kawashima T, et al. 2008. MURC, a muscle-restricted coiled-coil protein that modulates the Rho/ROCK pathway, induces cardiac dysfunction and conduction disturbance. Mol Cell Biol 28:3424-36. doi: 10.1128/MCB.02186-07.
70. Pani B, Singh BB. 2009. Lipid rafts/caveolae as microdomains of calcium signaling. Cell Calcium 45:625-33. doi: 10.1016/j.ceca.2009.02.009.
71. Papapetropoulos A, Fulton D, Mahboubi K, Kalb RG, O'Connor DS, Li F, et al. 2000. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 275:9102-5. doi: 10.1074/jbc.275.13.9102.
72. Park WY, Park JS, Cho KA, Kim DI, Ko YG, Seo JS, et al. 2000. Up-regulation of caveolin attenuates epidermal growth factor signaling in senescent cells. J Biol Chem 275:20847-52. doi: 10.1074/jbc.M908162199.
73. Parton RG, del Pozo MA. 2013. Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol 14:98-112. doi: 10.1038/nrm3512.
74. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, et al. 2001. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276:38121-38. doi: 10.1074/jbc.M105408200.
75. Razani B, Park DS, Miyanaga Y, Ghatpande A, Cohen J, Wang XB, et al. 2002. Molecular cloning and developmental expression of the caveolin gene family in the amphibian Xenopus laevis. Biochemistry 41:7914-24. doi: 10.1021/bi020043n.
76. Rohlich P, Allison AC. 1976. Oriented pattern of membrane-associated vesicles in fibroblasts. J Ultrastruct Res 57:94-103. doi: 10.1016/S0022-5320(76)80059-7.
77. Saito M, Hanson PI, Schlesinger P. 2007. Luminal chloride-dependent activation of endosome calcium channels: patch clamp study of enlarged endosomes. J Biol Chem 282:27327-33. doi: 10.1074/jbc.M702557200.
78. Schleicher M, Yu J, Murata T, Derakhshan B, Atochin D, Qian L, et al. 2009. The Akt1-eNOS axis illustrates the specificity of kinase-substrate relationships in vivo. Sci Signal 2:ra41. doi: 10.1126/scisignal.2000343.
79. Shen N, Gong T, Wang JD, Meng FL, Qiao L, Yang RL, et al. 2011. Cigarette smoke-induced pulmonary inflammatory responses are mediated by EGR-1/GGPPS/MAPK signaling. Am J Pathol 178:110-8. doi: 10.1016/j.ajpath.2010.11.016.
80. Singer II. 1979. Microfilament bundles and the control of pinocytotic vesicle distribution at the surfaces of normal and transformed fibroblasts. Exp Cell Res 122:251-64. doi: 10.1016/0014-4827(79)90302-1.
81. Smart EJ, Ying YS, Mineo C, Anderson RG. 1995. A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc Natl Acad Sci USA 92:10104-8. doi: 10.1073/pnas.92.22.10104.
82. Soria JC, Lee HY, Lee JI, Wang L, Issa JP, Kemp BL, et al. 2002. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin Cancer Res 8:1178-84.
83. Stan RV, Kubitza M, Palade GE. 1999. PV-1 is a component of the fenestral and stomatal diaphragms in fenestrated endothelia. Proc Natl Acad Sci USA 96:13203-7. doi: 10.1073/pnas.96.23.13203.
84. Stockhausen MT, Sjolund J, Axelson H. 2005. Regulation of the Notch target gene Hes-1 by TGFalpha induced Ras/MAPK signaling in human neuroblastoma cells. Exp Cell Res 310:218-28. doi: 10.1016/j.yexcr.2005.07.011.
85. Teixeira A, Chaverot N, Schroder C, Strosberg AD, Couraud PO, Cazaubon S. 1999. Requirement of caveolae microdomains in extracellular signal-regulated kinase and focal adhesion kinase activation induced by endothelin-1 in primary astrocytes. J Neurochem 72:120-8. doi: 10.1046/j.1471-4159.1999.0720120.x.
86. Tisdale MJ. 2002. Cachexia in cancer patients. Nat Rev Cancer 2:862-71. doi: 10.1038/nrc927.
87. Tong SY, Ki KD, Lee JM, Kang MJ, Ha TK, Chung SI, et al. 2010. Frequent inactivation of hSRBC in ovarian cancers by promoter CpG island hypermethylation. Acta Obstet Gynecol Scand 89:629-35. doi: 10.3109/00016341003678443.
88. van Dijk M, Visser A, Posthuma J, Poutsma A, Oudejans CB. 2012. Naturally occurring variation in trophoblast invasion as a source of novel (epigenetic) biomarkers. Front Genet 3:22. doi: 10.3389/fgene.2012.00022.
89. Van Kanegan MJ, Adams DG, Wadzinski BE, Strack S. 2005. Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt. J Biol Chem 280:36029-36. doi: 10.1074/jbc.M506986200.
90. Wallace DC. 2005. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:359-407. doi: 10.1146/annurev.genet.39.110304.095751.
91. Wang PY, Liu P, Weng J, Sontag E, Anderson RG. 2003. A cholesterol-regulated PP2A/HePTP complex with dual specificity ERK1/2 phosphatase activity. EMBO J 22:2658-67. doi: 10.1093/emboj/cdg255.
92. Waters CM, Hancock DC, Evan GI. 1990. Identification and characterisation of the egr-1 gene product as an inducible, short-lived, nuclear phosphoprotein. Oncogene 5:669-74.
93. Wikman H, Sielaff-Frimpong B, Kropidlowski J, Witzel I, Milde-Langosch K, Sauter G, et al. 2012. Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases. PLOS ONE 7:e47537. doi: 10.1371/journal.pone.0047537.
94. Xu XL, Wu LC, Du F, Davis A, Peyton M, Tomizawa Y, et al. 2001. Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. Cancer Res 61:7943-9.
95. Yamamoto T, Davis CG, Brown MS, Schneider WJ, Casey ML, Goldstein JL, et al. 1984. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell 39:27-38. doi: 10.1016/0092-8674(84)90188-0.
96. Yu X, Shen N, Zhang ML, Pan FY, Wang C, Jia WP, et al. 2011. Egr-1 decreases adipocyte insulin sensitivity by tilting PI3K/Akt and MAPK signal balance in mice. EMBO J 30:3754-65. doi: 10.1038/emboj.2011.277.
97. Zhao Z, Michaely P. 2008. The epidermal growth factor homology domain of the LDL receptor drives Lipoprotein release through an allosteric mechanism involving H190, H562, and H586. J Biol Chem 283:26528-37. doi: 10.1074/jbc.M804624200.
98. Zhu T, Beckingham K, Ikebe M. 1998. High affinity Ca2+ binding sites of calmodulin are critical for the regulation of myosin Ibeta motor function. J Biol Chem 273:20481-6. doi: 10.1074/jbc.273.32.20481.
99. Zochbauer-Muller S, Fong KM, Geradts J, Xu X, Seidl S, End-Pfutzenreuter A, et al. 2005. Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation. Oncogene 24:6249-55. doi: 10.1038/sj.onc.1208775.